ICICI Prudential Nifty Pharma Index Fund
Gland Pharma Limited · NSE
13,178 sh · ₹3.82 Cr
HDFC Mid Cap Fund
1.6% of their portfolio
₹1,751.05 Cr
60,67,814 sh
SBI Large and Midcap Fund
2.2% of their portfolio
₹919.59 Cr
31,86,587 sh
Nippon India Growth Mid Cap Fund
1.6% of their portfolio
₹811.83 Cr
28,00,000 sh
Kotak Mahindra Mutual Fund
Fund
₹789.47 Cr
55,86,000 sh
Nippon India Small Cap Fund
0.7% of their portfolio
₹531.29 Cr
18,32,424 sh
HDFC Large and Mid Cap Fund
1.3% of their portfolio
₹404.01 Cr
14,00,000 sh
Axis Mutual Fund
Investor
₹383.57 Cr
27,14,000 sh
ICICI Prudential India Opportunities Fund
1.0% of their portfolio
₹366.35 Cr
12,63,529 sh
Nippon India Multi Cap Fund
0.6% of their portfolio
₹346.15 Cr
11,93,854 sh
SBI Contra Fund
67.0% of their portfolio
₹321.20 Cr
11,13,026 sh
ICICI Prudential Mutual Fund
Fund
₹293.68 Cr
20,78,000 sh
Nippon India ELSS Tax Saver Fund
2.1% of their portfolio
₹289.94 Cr
10,00,000 sh
FIIs raised their stake +1.4pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
ICICI Prudential Nifty Pharma Index Fund
Gland Pharma Limited · NSE
13,178 sh · ₹3.82 Cr
Groww Mutual Fund (scheme IB18)
Gland Pharma Limited · NSE
1,409 sh · ₹40.85 L
ICICI Prudential Active Momentum Fund
Gland Pharma Limited · NSE
1,34,685 sh · ₹39.05 Cr
Groww Mutual Fund (scheme IB20)
Gland Pharma Limited · NSE
4,838 sh · ₹1.40 Cr
Groww Mutual Fund (scheme IB71)
Gland Pharma Limited · NSE
946 sh · ₹27.43 L
Nippon India Multi Cap Fund
Gland Pharma Limited · NSE
11,93,854 sh · ₹346.15 Cr
ICICI Prudential India Opportunities Fund
Gland Pharma Limited · NSE
12,63,529 sh · ₹366.35 Cr
ICICI Prudential Nifty 500 Index Fund
Gland Pharma Limited · NSE
423 sh · ₹12.26 L
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
73 announcements on record for this company.
ICICI Prudential Manufacturing Fund
1.0% of their portfolio
₹69.31 Cr
2,39,034 sh
Promoter holding by quarter: Jun 2025 51.8%, Sep 2025 51.8%, Dec 2025 51.8%, Mar 2026 51.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.3pp
FII holding by quarter: Jun 2025 7.4%, Sep 2025 7.9%, Dec 2025 7.6%, Mar 2026 7.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— +0.4pp
DII holding by quarter: Jun 2025 32.9%, Sep 2025 32.6%, Dec 2025 33.0%, Mar 2026 33.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.4pp
MF holding by quarter: Jun 2025 30.7%, Sep 2025 30.2%, Dec 2025 31.4%, Mar 2026 31.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
ICICI Prudential Quality Fund
Gland Pharma Limited · NSE
47,807 sh · ₹13.86 Cr
ICICI Prudential Healthcare Fund
Gland Pharma Limited · NSE
4,65,318 sh · ₹134.91 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 51.8%, Sep 2025 51.8%, Dec 2025 51.8%, Mar 2026 51.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.3pp
FII holding by quarter: Jun 2025 7.4%, Sep 2025 7.9%, Dec 2025 7.6%, Mar 2026 7.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— +0.4pp
DII holding by quarter: Jun 2025 32.9%, Sep 2025 32.6%, Dec 2025 33.0%, Mar 2026 33.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— +0.4pp
MF holding by quarter: Jun 2025 30.7%, Sep 2025 30.2%, Dec 2025 31.4%, Mar 2026 31.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
73 announcements on record for this company.